Full Text View
Tabular View
No Study Results Posted
Related Studies
Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure
This study has been terminated.
( A preliminary analysis of 11 patients confirmed the safety profile of NCX-1000 but did not demonstrate the efficacy required. )
Study NCT00414869   Information provided by Axcan Pharma
First Received: December 21, 2006   Last Updated: November 16, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Portal Hypertension
Additional conditions recognized in this trial
Hypertension
Hypertension, Portal
More general conditions related to this trial
Cardiovascular Diseases
Digestive System Diseases
Liver Diseases
Vascular Diseases
Interventions listed in this trial
NCX-1000
Sponsors listed in this trial
Axcan Pharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services